Who is the CEO of Paradigm Biopharmaceuticals Limited?

The CEO of Paradigm Biopharmaceuticals Limited is Paul John Rennie BSc, Grad Dip, MBM, MSTC.

What industry does Paradigm Biopharmaceuticals Limited belong to?

Paradigm Biopharmaceuticals Limited operates in the Biotechnology industry within the Healthcare sector.

Where is Paradigm Biopharmaceuticals Limited headquartered?

Paradigm Biopharmaceuticals Limited is headquartered at 500 Collins Street, Melbourne, VIC, 3000, AU.

What is the IPO date of Paradigm Biopharmaceuticals Limited?

Paradigm Biopharmaceuticals Limited went public on May 10, 2019.

How many employees does Paradigm Biopharmaceuticals Limited have?

The total number of employees at Paradigm Biopharmaceuticals Limited is disclosed periodically in the company's annual financial reports.

Paradigm Biopharmaceuticals Limited

PBIGF•PNK

Healthcare

Biotechnology

$0.23

$0.00(0.00%)

Paradigm Biopharmaceuticals Limited (PBIGF) Company Profile & Overview

Explore Paradigm Biopharmaceuticals Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Paradigm Biopharmaceuticals Limited (PBIGF) Company Profile & Overview

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

SectorHealthcare

IndustryBiotechnology

CEOPaul John Rennie BSc, Grad Dip, MBM, MSTC

Contact Information

https://www.paradigmbiopharma.com

61 3 9629 5566

500 Collins Street, Melbourne, VIC, 3000

Company Facts

IPO DateMay 10, 2019

CountryAU

Actively Trading

Frequently Asked Questions

;